Skip to search formSkip to main contentSkip to account menu

TX 1877

Known as: TX-1877, TX1877 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

2-nitroimidazole acetamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Structure-associated Functional Control of TX-1877 Series by Glyco-conjugation
Background/Aim: Sugar molecules are often used as a tool to structurally modify chemical compounds. The features of synthesized… 
2009
2009
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer
PurposeIt is well known that hypoxic milieu is the primary cancer environment. Therefore, tumor hypoxia is considered to be a… 
2008
2008
Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizers.
2008
2008
The novel hypoxic cell radiosensitizer, TX-1877 has antitumor activity through suppression of angiogenesis and inhibits liver metastasis on xenograft model of pancreatic cancer.
2005
2005
TX‐1877, a bifunctional hypoxic cell radiosensitizer, enhances anticancer host response: Immune cell migration and nitric oxide production
We investigated in the current study the effect of TX‐1877, a bifunctional hypoxic cell radiosensitizer, in augmenting anticancer… 
2002
2002
Comparison of hypoxic cell radiosensitizers, KIN-804, KIN-844, KIN-806 and TX-1877, on brain and liver metabolizing capacities in mice bearing Ehrlich ascites carcinoma.
The biochemical effects of the 2-nitroimidazole hypoxic cell radiosensitizers KIN-804, KIN-806, and their analogues KIN-844 and… 
2001
2001
New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
1998
1998
TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)